SCHEMBL29489154

SCHEMBL29489154

CNC(=O)COC(=O)NCCC1CCN(c2cccc(C)n2)CC1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TGM2 P21980 2/20 0.44
GPBAR1 Q8TDU6 1/20 0.42
HTR1A P08908 4/20 0.41
HTR2A P28223 3/20 0.41
DRD3 P35462 2/20 0.41
ACACB O00763 3/20 0.41
FAAH O00519 1/20 0.40
CHRM4 P08173 3/20 0.40
PDE10A Q9Y233 1/20 0.39
MAP4K4 O95819 1/20 0.39
ACACA Q13085 1/20 0.38
DRD2 P14416 1/20 0.38
DRD4 P21917 1/20 0.38
HTR3E A5X5Y0 1/20 0.38
HTR3B O95264 1/20 0.38
HTR3A P46098 1/20 0.38
HTR3D Q70Z44 1/20 0.38
HTR3C Q8WXA8 1/20 0.38
SUV39H2 Q9H5I1 1/20 0.38
HTR2C P28335 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL240877 1.00 TGM2 (0.44) TGM2GPBAR1HTR1AHTR2ADRD3
Hydrochloric Acid SCHEMBL238862 0.99 TGM2 (0.43) TGM2GPBAR1HTR1AHTR2ADRD3
SCHEMBL3268986 0.91 HSD11B1 (0.41) ACACBFAAHCHRM4MAP4K4ACACA
SCHEMBL3266800 0.88 ACACB (0.40) HTR1AACACBFAAHCHRM4MAP4K4
SCHEMBL3265570 0.87 ACACB (0.42) HTR1AACACBFAAHCHRM4MAP4K4
SCHEMBL3265488 0.87 FAAH (0.40) ACACBFAAHCHRM4MAP4K4ACACA
SCHEMBL240061 0.86 HRH3 (0.39) TGM2ACACBFAAHCHRM4MAP4K4
SCHEMBL3266796 0.85 CHRM4 (0.48) DRD3FAAHCHRM4DRD2
SCHEMBL241775 0.84 ACACB (0.44) DRD3ACACBPDE10AMAP4K4ACACA
SCHEMBL3265480 0.83 PTGES (0.45) FAAHCHRM4PDE10AMAP4K4SUV39H2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250281419-A1 LIPID AMINES ARES CAPITAL CORPORATION, AS AGENT 2025-09-11 US claimed
CN-119644843-A Auxiliary driving controller and system based on national product chip 东风汽车集团股份有限公司 2025-03-18 CN claimed
US-20250372066-A1 INFORMATION PROCESSING METHOD AND ELECTRONIC KEYBOARD INSTRUMENT YAMAHA CORP (JP) 2025-12-04 US disclosed
US-20250281419-A1 LIPID AMINES ARES CAPITAL CORPORATION, AS AGENT 2025-09-11 US disclosed
US-20250235531-A1 MUCOSAL ADMINISTRATION METHODS AND FORMULATIONS MODERNATX, INC. (US) 2025-07-24 US disclosed
CN-119644843-A Auxiliary driving controller and system based on national product chip 东风汽车集团股份有限公司 2025-03-18 CN disclosed
US-12223832-B2 System and method for emergency vehicle detection and alerting Alert The Mechanism LLC (US) 2025-02-11 US disclosed
EP-4496896-A2 MICROBIAL CONSORTIA FOR SOIL IMPROVEMENT Pluton Biosciences, Inc. (US) 2025-01-29 EP disclosed
CN-119278272-A Microbial consortium for soil improvement 深成岩体生物科学有限公司 2025-01-07 CN disclosed
EP-4475882-A1 MUCOSAL ADMINISTRATION METHODS AND FORMULATIONS ModernaTX, Inc. (US) 2024-12-18 EP disclosed
US-20240296735-A1 SYSTEM AND METHOD FOR EMERGENCY VEHICLE DETECTION AND ALERTING Alert The Mechanism LLC (US) 2024-09-05 US disclosed
US-20240018064-A1 MICROBIAL CONSORTIA FOR SOIL IMPROVEMENT Pluton Biosciences, Inc 2024-01-18 US disclosed
EP-4288152-A2 ANTIBODIES RQ Biotechnology Limited (GB) 2023-12-13 EP disclosed
US-20230377459-A1 SYSTEM AND METHOD FOR EMERGENCY VEHICLE DETECTION AND ALERTING Alert The Mechanism LLC (US) 2023-11-23 US disclosed
WO-2023183783-A2 MICROBIAL CONSORTIA FOR SOIL IMPROVEMENT PLUTON BIOSCIENCES, INC. (US) 2023-09-28 WO disclosed
WO-2023283977-A1 USE OF PREPARATION FOR INHIBITING OR BLOCKING INTERACTION BETWEEN FAAH AND NLRP3 华南理工大学 2023-01-19 WO disclosed
CN-115616216-A Use of an agent that inhibits or blocks the interaction between FAAH and NLRP3 华南理工大学 2023-01-17 CN disclosed
CN-217731649-U Conveying belt driving roller 广东中烟工业有限责任公司 2022-11-04 CN disclosed
WO-2022167816-A2 ANTIBODIES OXFORD UNIVERSITY INNOVATION LIMITED (GB) 2022-08-11 WO disclosed
CN-107871523-B Semiconductor memory device with a plurality of memory cells 铠侠股份有限公司 2022-03-04 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250235531-A1 MUCOSAL ADMINISTRATION METHODS AND FORMULATIONS MUC1, RNMT, FABP2 TGM2 3925/4885GPBAR1 1237/4885HTR1A 2543/4885
US-20250281419-A1 LIPID AMINES SGMS1, PHOSPHO1, SGMS2 TGM2 2327/4885GPBAR1 94/4885HTR1A 336/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.